stroke
Conditions
Interventions
This research is a randomized, sham-controlled clinical study of a quantitative nature. The experimental group: 40 individuals who had a stroke in the last three months received treatment with transcr
E02.594.540
Sponsors
Universidade do Sul de Santa Catarina
Universidade do Sul de Santa Catarina
Eligibility
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Participants of both sexes; age between eighteen and fifty-nine years; up to three months from the episode of unilateral ischemic stroke; not neglecting paretic limbs; hemodynamically stable; without peripheral neuritis; able to understand and follow simple verbal instructions
Exclusion criteria
Exclusion criteria: Inability to understand questionnaires; hypersensitivity to light; oncological pathologies; infectious pathologies; post-surgical spinal procedures; rheumatic diseases; renal diseases; hepatic diseases; untreated gastrointestinal diseases; untreated psychiatric diseases; immunosuppression; pregnant women; lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction of inflammatory markers of at least 10%, through blood bioassays caused by the neuroinflammation cascade after the stroke. Data collected 1 day before the intervention, in the sixth week of intervention and in the twelfth, which is the last week of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life outcomes, assessed by the quality of life scale indicated for individuals after stroke, are expected to increase by 10 points, indicating at least a reasonable improvement in quality of life | — |
Countries
Brazil
Contacts
Public ContactLetícia Napoleão
Universidade do Sul de Santa Catarina
Outcome results
None listed